Skip to content

The Effect of Caloric Supplement in the Clinical Outcomes in Acute Lung Injury Patients

The Effect of Caloric Supplement in the Clinical Outcomes in Acute Lung Injury Patients

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04262440
Enrollment
200
Registered
2020-02-10
Start date
2019-04-11
Completion date
2022-12-31
Last updated
2020-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ARDS

Brief summary

The optimal amount caloric intake were still controversy in critically ill patients in literature. There were no significant outcome difference with different caloric intake in acute lung injury patients. In order to identify the optimal amount caloric intake in acute lung injury patients, we conduct a prospectively observational study to see whether the caloric differences influence hospital mortality.

Detailed description

The is a prospectively observational study. The data including basic demographic data, daily PN/EN caloric intake, days of ICU stay, days of hospital stay, hospital mortality, days of ventilator use.. will be collected. Statistic analysis included chi-square, student t test, logistic regression and ROC curve will be applied to analyze the different characteristics between survived and died patients. Also we can figure out the optimal cut value of caloric intake with best outcome by ROC curve analysis. We plan enrolled 200 participants within study period.

Interventions

None listed

Sponsors

Taichung Veterans General Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Age older than 20 year old Respiratory failure with ventilator Fit the diagnostic criteria of ARDS (2012 Berlin Criteria)

Exclusion criteria

Expected ICU stay less than 72 hours

Design outcomes

Primary

MeasureTime frame
Hospital mortalitythrough study completion, an average of 1 year

Countries

Taiwan

Contacts

Primary ContactCHEN-YU WANG, MHA
chestmen@gmail.com886-04-23592525

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026